(Q33369255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Phase II trial of temozolomide in children with recurrent high-grade glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

phase II clinical trial

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Maria Luisa Garrè

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Maura Massimino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Palma Maurizi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Riccardo Riccardi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

G Cefalo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Colosimo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Attinà

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

I Lazzareschi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

V Ridola

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Mazzarella

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Caldarelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Di Rocco

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

E Madon

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M E Abate

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Clerico

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Sandri

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

89-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

Survival of children with brain tumors: SEER Program, 1973-1980.

9 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9011-2

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9011-2

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9011-2

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.

1 reference

12 December 2020

DNA damage and differential cytotoxicity produced in human cells by 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947), a new DNA-chloroethylating agent

1 reference

12 December 2020

Supratentorial malignant gliomas in childhood: a review of fifty cases

1 reference

12 December 2020

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

1 reference

12 December 2020

Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study

1 reference

12 December 2020

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

1 reference

12 December 2020

Chemotherapy for high-grade gliomas of childhood

1 reference

12 December 2020

Practical decisions in the treatment of pediatric brain stem tumors

1 reference

12 December 2020

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy.

1 reference

12 December 2020

Temozolomide and treatment of malignant glioma.

1 reference

12 December 2020

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

1 reference

12 December 2020

Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients

1 reference

12 December 2020

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

12 December 2020

Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer

1 reference

12 December 2020

Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model

1 reference

12 December 2020

Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.

1 reference

12 December 2020

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

12 December 2020

Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas

1 reference

12 December 2020

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine

1 reference

12 December 2020

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group

1 reference

12 December 2020

A staging system for brain stem gliomas

1 reference

12 December 2020

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

12 December 2020

Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase

1 reference

12 December 2020

UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group

1 reference

12 December 2020

Chemotherapy for brain stem gliomas

1 reference

12 December 2020

High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis.

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

10.1007/S11060-005-9011-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16292488%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 January 2020

1000517725

0 references

1 reference